BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

dc.contributor.authorAlvarez Aguilera, Carolina Soledad
dc.contributor.authorTapia, Teresa
dc.contributor.authorPérez Moreno, Elisa Valentina
dc.contributor.authorGajardo Meneses, Patricia
dc.contributor.authorRuiz, Catalina
dc.date.accessioned2020-07-23T15:51:56Z
dc.date.available2020-07-23T15:51:56Z
dc.date.issued2017
dc.fuente.origenConveris
dc.identifier.doi10.18632/oncotarget.18815
dc.identifier.issn1949-2553
dc.identifier.urihttps://doi.org/10.18632/oncotarget.18815
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/37133
dc.issue.numeroNo. 43
dc.language.isoen
dc.nota.accesoContenido completo
dc.pagina.final74243
dc.pagina.inicio74233
dc.revistaOncotargetes_ES
dc.rightsacceso abierto
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherCáncer de mamaes_ES
dc.subject.otherGenes cancerígenoses_ES
dc.subject.otherTumoreses_ES
dc.titleBRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chilees_ES
dc.typeartículo
dc.volumenVol. 8
sipa.codpersvinculados15128
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.pdf
Size:
10.72 MB
Format:
Adobe Portable Document Format
Description: